We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$172M
Cap. Flow
+$156M
Cap. Flow %
7.83%
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294

Sector Composition

Rank Sector Weight
1 Healthcare 2.95%
2 Consumer Discretionary 2.51%
3 Technology 1.96%
4 Energy 1.43%
5 Communication Services 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLH
276
CALL
DELISTED
WILLIAM LYON HOMES
WLH
$1.73M 0.09%
+95,000
New +$1.71M
TPB icon
277
Turning Point Brands
TPB
$1.45B
$1.73M 0.09%
+35,300
New +$1.7M
HOME
278
DELISTED
At Home Group Inc.
HOME
$1.72M 0.09%
+257,500
New +$4.56M
PRGO icon
279
Perrigo
PRGO
$1.4B
$1.71M 0.09%
+36,000
New +$1.71M
TSG
280
CALL
DELISTED
The Stars Group Inc.
TSG
$1.71M 0.09%
100,000
FBIN icon
281
CALL
Fortune Brands Innovations
FBIN
$5.88B
$1.7M 0.09%
+34,866
New +$1.55M
MSGS icon
282
PUT
Madison Square Garden
MSGS
$9.48B
$1.68M 0.08%
+8,412
New +$1.79M
AXSM icon
283
CALL
Axsome Therapeutics
AXSM
$11.2B
$1.67M 0.08%
65,000
-22,500
-26% -$451K
BC icon
284
CALL
Brunswick
BC
$5.13B
$1.65M 0.08%
+36,000
New +$1.74M
IRWD icon
285
CALL
Ironwood Pharmaceuticals
IRWD
$696M
$1.64M 0.08%
150,000
+9,824
+7% +$110K
UVV icon
286
PUT
Universal Corp
UVV
$1.31B
$1.64M 0.08%
+27,000
New +$1.51M
MRNS
287
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.64M 0.08%
98,800
+36,300
+58% +$630K
MET icon
288
CALL
MetLife
MET
$61.9B
$1.63M 0.08%
+32,900
New +$1.55M
TBPH icon
289
PUT
Theravance Biopharma
TBPH
$874M
$1.63M 0.08%
100,000
+50,000
+100% +$1.01M
VSAT icon
290
PUT
Viasat
VSAT
$10.6B
$1.62M 0.08%
+20,000
New +$1.75M
OXY icon
291
Occidental Petroleum
OXY
$56.8B
$1.61M 0.08%
+32,000
New +$1.8M
LEN icon
292
Lennar Class A
LEN
$19.8B
$1.6M 0.08%
+34,089
New +$1.7M
AMAG
293
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
$1.6M 0.08%
+160,000
New +$1.73M
AMAG
294
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
$1.6M 0.08%
+160,000
New +$1.73M
BLUE
295
PUT
DELISTED
bluebird bio
BLUE
$1.59M 0.08%
965
-965
-50% -$1.67M
KRNT icon
296
CALL
Kornit Digital
KRNT
$705M
$1.58M 0.08%
50,000
KRNT icon
297
PUT
Kornit Digital
KRNT
$705M
$1.58M 0.08%
50,000
NBIS
298
Nebius Group N.V.
NBIS
$48.3B
$1.52M 0.08%
40,000
+30,000
+300% +$1.11M
CCJ icon
299
Cameco
CCJ
$37.6B
$1.5M 0.08%
140,000
+35,000
+33% +$377K
STAY
300
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$1.5M 0.08%
88,967
+18,967
+27% +$335K

Similar funds

Caption Management's Q2 2019 Portfolio in Review

As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.

  • Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
  • Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
  • Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
  • Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
  • Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
  • Caption Management opened 395 new positions and closed 294 in Q2 2019.
  • Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.

Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.